TDI Episode 49: Pharma Huckman’s Market

March 23, 2008

Guest: Mike Huckman, CNBC Pharmaceutical Reporter brings great deal of timely information regarding the Pharma and Biotech sectors. We discuss Merck (MRK), Amgen (AMGN), Genentech (DNA), Dendreon (DNDN), Pfizer (PFE) and others.

Mike’s writes a terrific blog and appears daily on CNBC.

Mike Huckman

Andrew discusses the current markets and provides a few strategic moves for profit potential. Last week was a see-saw market and if positioned correctly, your portfolio could be holding up well. Even so, it looks as though the economic environment could continue to deteriorate. In this episode, we explore the next looming problem and how to protect yourself.

**AWARENESS and discussion of the Credit Card Crisis has not yet made it to the mainstream headlines, but we see that there is potential for additional economic fallout as Americans continue to build credit in order to pay for their increasingly expensive lifestyles.**

In this edition of The ZachZone, Visa (V) and upcoming IPOs are discussed.

Newsflashr

(This edition of The ZachZone is sponsored by Newsflashr - Get a wide angle view of all of the hot topics making news - All on a single page. )

~ Listen and Subscribe in iTunes ~


Other Stocks Mentioned in this and recent episodes: (V) (BSC) (LEH) (SPY) (SAFM) (GS) (MER) (QID) (SKF) (QQQQ) (IBKR)

Related Posts:

  1. TDI Episode 89: Crashproof’n with Peter Schiff Guest: Peter Schiff, Author of Crashproof and President of Euro Pacific Capital....
  2. TDI Episode 88: The Shocking Employment Numbers Guest: Charles Biderman - TrimTabs, Founder and CEO. We discuss the flow...
  3. TDI Episode 66: Stock Tips and Mish-O-Nomics Guest: Michael "Mish" Shedlock and Andrew discuss the current economy, the financials...
  4. TDI Podcast 85: PinPoint Charting the Next Market Move Guest: Brian Shannon, AlphaTrends.net provides insight and direction of this ever confusing...
  5. TDI Episode 90: The Everything ETF Episode (Part 1) Guest: Tom Lydon, Global ETF Trends and Andrew cover the ETF universe...

Comments